Details for Patent: RE49582
✉ Email this page to a colleague
Which drugs does patent RE49582 protect, and when does it expire?
Patent RE49582 protects PYRUKYND and is included in one NDA.
This patent has sixty-one patent family members in thirty-seven countries.
Drugs Protected by US Patent RE49582
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE49582
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2448582 | ⤷ Sign Up | 301230 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2448582 | ⤷ Sign Up | CA 2023 00014 | Denmark | ⤷ Sign Up |
| European Patent Office | 2448582 | ⤷ Sign Up | 2023C/517 | Belgium | ⤷ Sign Up |
| European Patent Office | 2448582 | ⤷ Sign Up | LUC00306 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2448582 | ⤷ Sign Up | PA2023513 | Lithuania | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
